TRCT
FFTY icon

Tower Research Capital (TRC)’s CapForce IBD 50 ETF FFTY Stock Holding History

Tower Research Capital (TRC)’s Portfolio FFTY Stock Details FFTY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$960K Buy
28,725
+17,869
+165% +$664K 0.02% 554
2025
Q4 		$378K Buy
10,856
+3,556
+49% +$131K 0.01% 995
2025
Q3 		$273K Buy
7,300
+7,200
+7,200% +$249K 0.01% 1247
2025
Q2 		$3.25K Sell
100
-14,432
-99% -$412K ﹤0.01% 4529
2025
Q1 		$392K Sell
14,532
-693
-5% -$20.3K 0.01% 983
2024
Q4 		$435K Buy
15,225
+4,883
+47% +$142K 0.01% 1162
2024
Q3 		$278K Sell
10,342
-9,780
-49% -$257K 0.01% 1321
2024
Q2 		$559K Buy
20,122
+1,981
+11% +$54K 0.01% 1247
2024
Q1 		$501K Buy
18,141
+1,699
+10% +$44.4K 0.01% 861
2023
Q4 		$401K Buy
16,442
+43
+0.3% +$978 ﹤0.01% 1551
2023
Q3 		$367K Buy
+16,399
New +$396K 0.01% 1057
2023
Q2 		– Sell
-23,298
Closed -$551K – 6136
2023
Q1 		$551K Sell
23,298
-12,767
-35% -$293K 0.02% 768
2022
Q4 		$787K Buy
36,065
+6,340
+21% +$156K 0.03% 476
2022
Q3 		$727K Buy
29,725
+6,042
+26% +$167K 0.01% 867
2022
Q2 		$636K Buy
23,683
+6,265
+36% +$201K 0.01% 978
2022
Q1 		$680K Buy
17,418
+463
+3% +$18K 0.01% 976
2021
Q4 		$778K Buy
16,955
+16,737
+7,678% +$799K 0.01% 840
2021
Q3 		$10K Sell
218
-39,511
-99% -$1.85M ﹤0.01% 4311
2021
Q2 		$1.84M Buy
39,729
+27,306
+220% +$1.24M 0.05% 340
2021
Q1 		$545K Buy
+12,423
New +$564K 0.01% 1172
2020
Q4 		– Sell
-18,668
Closed -$696K – 5205
2020
Q3 		$696K Buy
18,668
+9,289
+99% +$342K 0.01% 1320
2020
Q2 		$323K Sell
9,379
-33,627
-78% -$1.04M 0.01% 1379
2020
Q1 		$1.2M Buy
43,006
+30,076
+233% +$1M 0.07% 191
2019
Q4 		$449K Sell
12,930
-48,558
-79% -$1.64M 0.04% 296
2019
Q3 		$1.99M Buy
61,488
+27,249
+80% +$932K 0.14% 121
2019
Q2 		$1.17M Buy
34,239
+18,511
+118% +$624K 0.08% 222
2019
Q1 		$527K Sell
15,728
-61,830
-80% -$1.95M 0.03% 569
2018
Q4 		$2.14M Buy
+77,558
New +$2.41M 0.15% 133

Other funds holding FFTY

CPA
Clear Point Advisors Melville, New York $129M AUM 12.02% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
IWM
IHT Wealth Management Chicago, Illinois $4.3B AUM 21.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CFP
Comprehensive Financial Planning East Petersburg, Pennsylvania $144M AUM 25.61% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
DSCM
Del-Sette Capital Management Schenectady, New York $167M AUM 38.06% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Tower Research Capital (TRC)'s FFTY Position: Q1 2026 in Review

Tower Research Capital (TRC) increased its CapForce IBD 50 ETF (FFTY) stake by 165% in Q1 2026, buying an estimated $664K and bringing the position to 28,725 shares worth $960K. The position accounts for 0.02% of the portfolio, ranked #554.

Tower Research Capital (TRC) first reported a position in FFTY in Q4 2018 and has held it in 28 quarters since. The position peaked at $2.14M in Q4 2018. 39 funds tracked by Wall St. Rank hold FFTY as of Q1 2026.

  • Tower Research Capital (TRC) held 28,725 shares of CapForce IBD 50 ETF worth $960K as of Q1 2026.
  • Tower Research Capital (TRC) bought 17,869 CapForce IBD 50 ETF shares in Q1 2026, an estimated $664K.
  • CapForce IBD 50 ETF made up 0.02% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #554 holding.
  • Tower Research Capital (TRC) first reported a position in CapForce IBD 50 ETF in Q4 2018 and has held it in 28 quarters since.
  • Tower Research Capital (TRC)'s CapForce IBD 50 ETF position peaked at $2.14M in Q4 2018.
  • 39 funds tracked by Wall St. Rank held CapForce IBD 50 ETF as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.